This conference brings together stakeholders in the orphan drugs industry to discuss and network with top tier government, pharmaceuticals, biotechs, non-profit organisations, orphan drug developers, research organisations as well as patients groups and advocates.
Dr Jonathan Appleby, Chief Scientific Officer
Chairing keynote panel discussion
Cell and Gene Therapies for Rare Diseases: Solutions for realising the potential of the next generation of medicine
11.15-12.00, Tuesday 20th October 2020
Find out more and register here